The purpose of this trial is to evaluate the effect of tadalafil 5 milligrams (mg) daily for
8 weeks compared to placebo on prostatic blood perfusion in men with signs and symptoms of
Benign Prostatic Hyperplasia (BPH), measured by resistive index (RI) in the prostate
transition zone.